The METOCARD-CNIC ( Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction ) trial recruited 270 patients with Killip class II anterior STEMI presenting early after symptom onset ( < 6 h ) and randomized them to pre-reperfusion IV metoprolol or control group .